GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achilles Therapeutics PLC (NAS:ACHL) » Definitions » Credit Losses Provision

ACHL (Achilles Therapeutics) Credit Losses Provision


View and export this data going back to 2021. Start your Free Trial

What is Achilles Therapeutics Credit Losses Provision?

Credit Losses Provision only applies to banks.


Achilles Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
245 Hammersmith Road, London, GBR, W6 8PW
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.